"Nvidia has teamed up with pharmaceutical heavyweight Eli Lilly to plow up to $1 billion into a research lab over the next five years to advance the development of foundation models for AI-assisted drug discovery. Announced at the JPMorgan Healthcare conference on Monday, the collaboration will span the infrastructure, talent, and compute necessary to develop these biology and chemistry models using Nvidia's BioNeMo software platform and Vera Rubin accelerators."
"Once operational, Nvidia says the lab's first order of business will be to create a "continuous learning system that tightly connects Lilly's agentic wet labs with computational dry labs." The GPU slinger claims that this will enable "24/7 experimentation." We've reached out to Nvidia to ask what that actually means, but reading between the lines, it sounds like the teams will be building the equivalent of a continuous integration/continuous delivery (CI/CD) pipeline for AI-assisted drug research."
Nvidia and Eli Lilly will create a San Francisco Bay Area co-innovation lab with up to $1 billion in funding over five years to advance foundation models for biology and chemistry. The lab will pair Eli Lilly's biologists and chemists with Nvidia's software engineers and model developers and will use Nvidia's BioNeMo platform and Vera Rubin accelerators. Initial goals include building a continuous learning system that links wet labs and computational dry labs to enable round-the-clock experimentation and to automate AI-assisted experiment preparation and iteration.
Read at Theregister
Unable to calculate read time
Collection
[
|
...
]